Search clinical trials for: EO9

Total 4 results

Spectrum Pharmaceuticals, Inc
Allergan

Terminated

Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer

Bladder Cancer

United States, Canada
Spectrum Pharmaceuticals, Inc
Allergan

Terminated

Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC)

Bladder Cancer

United States, Poland, Czechia, Slovakia
Handok Inc.

Completed

Safety and Pharmacokinetic Study of EO9(Intravesical Instillation)

Bladder Cancer

Korea, Republic of
Nippon Kayaku Co., Ltd.
Handok Inc.

Terminated

Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)

Bladder Cancer

Japan, Korea, Republic of

3

Subscribe